Embody vs Maximus: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 15, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Embody scores higher on our rubric, 7.3/10 against 5.1/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Embody - our pick of these two →or find your match

Embody beats Maximus overall, scoring 7.3/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Maximus is published $79.99/mo; total not verified. Choose Embody for people who want the oral tirzepatide gum, or who are comfortable selecting a 4-, 12-, 24- or 52-week plan for an advertised glp-1 + gip rate from $129. Choose Maximus for men who want glp-1 alongside testosterone or other men's health protocols.

A side-by-side look at Embody and Maximus to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Embody

#32 of 54

7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan. Its standout is oral tirzepatide gum for people who do not want injections.

Visit Embody

Maximus

#50 of 54

5.1/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus

Feature	Embody	Maximus
Why each one	One of the few GLP-1 providers offering oral tirzepatide as a chewable gum, a real choice for people who don't want injections.	Only platform offering GLP-1 microdosing from $79.99/mo for BMI as low as 22, targeting the 'small weight loss' and metabolic health market.
Our Score	7.3/10	5.1/10
Headline Price	from $69/mo	published $79.99/mo; total not verified
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	People who want the oral tirzepatide gum, or who are comfortable selecting a 4-, 12-, 24- or 52-week plan for an advertised GLP-1 + GIP rate from $129	Men who want GLP-1 alongside testosterone or other men's health protocols
Watch out for	Runs two sibling storefronts most shoppers will never connect to it: SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com) are the same legal entity, Modern Metabolic Medicine, Inc. SnagRx still advertises a separate $69/$119 promotion; Embody now advertises $79/$129 under its own plan menu. Neither site tells shoppers they share an operator. See our [SnagRx review](/reviews/snagrx)	The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
Ranking	#32	#50
Get started	Visit Embody	Visit Maximus

Pros & Cons Compared

Embody

Pros

+Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
+Advertised injection floors of $79 for semaglutide and $129 for GLP-1 + GIP, verified August 14, 2026. The FAQ says the selected rate holds within the chosen plan.
+Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.
+100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
+Replies to every negative Trustpilot review, usually within 24 hours.

Cons

−Runs two sibling storefronts most shoppers will never connect to it: SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com) are the same legal entity, Modern Metabolic Medicine, Inc. SnagRx still advertises a separate $69/$119 promotion; Embody now advertises $79/$129 under its own plan menu. Neither site tells shoppers they share an operator. See our [SnagRx review](/reviews/snagrx)
−The $79/$129 figures are advertised floors tied to a selected 4-, 12-, 24- or 52-week plan, not a verified no-commitment month-to-month rate. Confirm the plan length and total before payment.
−Trustpilot rating is 3.8 / 5 across 5,305 reviews, verified August 14, 2026. Price and billing remain recurring complaint themes, although many reviews describe earlier pricing structures.
−Embody names four pharmacy partners: RedRock Pharmacy, Health Warehouse, Precision Compounding and Triad Rx. It does not state whether each prescription is filled through a 503A pharmacy or a 503B outsourcing facility. Triad Rx received a 2019 FDA warning letter for sterile-production violations; FDA closed it out in May 2023.
−No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info, most telehealth providers publish a statement confirming they follow it).
−Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
−If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy; raise your dose history at signup, the prescriber makes the final call.

Maximus

Pros

+Lowest published microdose medication price we track, $79.99/mo semaglutide; consultation and lab fees are separate
+GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
+Maximus markets a semaglutide formula with added glycine and B12 as a way to ease nausea; we found no Maximus-specific clinical trial validating that claim
+Free expedited shipping on all medication orders

Cons

−The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
−Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
−Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise
−FDA warning letter #730095, issued June 8, 2026, cites false or misleading compounded-GLP-1 marketing claims. It is a marketing/misbranding record, not an unsafe-medication finding

Our Verdict

Embody edges out Maximus with a score of 7.3/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Maximus is published $79.99/mo; total not verified.